1. Home
  2. RGEN vs INFA Comparison

RGEN vs INFA Comparison

Compare RGEN & INFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • INFA
  • Stock Information
  • Founded
  • RGEN 1981
  • INFA 1993
  • Country
  • RGEN United States
  • INFA United States
  • Employees
  • RGEN N/A
  • INFA N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • INFA EDP Services
  • Sector
  • RGEN Health Care
  • INFA Technology
  • Exchange
  • RGEN Nasdaq
  • INFA Nasdaq
  • Market Cap
  • RGEN 6.5B
  • INFA 5.6B
  • IPO Year
  • RGEN N/A
  • INFA 2021
  • Fundamental
  • Price
  • RGEN $119.75
  • INFA $24.80
  • Analyst Decision
  • RGEN Buy
  • INFA Hold
  • Analyst Count
  • RGEN 10
  • INFA 13
  • Target Price
  • RGEN $163.78
  • INFA $24.75
  • AVG Volume (30 Days)
  • RGEN 706.1K
  • INFA 2.8M
  • Earning Date
  • RGEN 11-11-2025
  • INFA 10-29-2025
  • Dividend Yield
  • RGEN N/A
  • INFA N/A
  • EPS Growth
  • RGEN N/A
  • INFA N/A
  • EPS
  • RGEN N/A
  • INFA N/A
  • Revenue
  • RGEN $673,956,000.00
  • INFA $1,662,027,000.00
  • Revenue This Year
  • RGEN $16.74
  • INFA $5.43
  • Revenue Next Year
  • RGEN $13.86
  • INFA $4.92
  • P/E Ratio
  • RGEN N/A
  • INFA N/A
  • Revenue Growth
  • RGEN 8.73
  • INFA 1.16
  • 52 Week Low
  • RGEN $102.97
  • INFA $15.65
  • 52 Week High
  • RGEN $182.52
  • INFA $28.14
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 50.04
  • INFA 57.02
  • Support Level
  • RGEN $112.73
  • INFA $24.76
  • Resistance Level
  • RGEN $122.71
  • INFA $24.81
  • Average True Range (ATR)
  • RGEN 4.63
  • INFA 0.05
  • MACD
  • RGEN -0.46
  • INFA -0.02
  • Stochastic Oscillator
  • RGEN 55.87
  • INFA 28.57

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About INFA Informatica Inc.

Informatica Inc provides artificial intelligence (AI) enabled data management products on a cloud native platform that connects, manages, and unifies data across multi-vendor, multi-cloud, and hybrid systems at an enterprise scale. The company's platform includes a suite of interoperable data management products that leverage the shared services and metadata of the underlying platform, including products for Data Catalog, Data Integration & Engineering, API & Application Integration, Data Quality and Observability, Master Data Management, Customer and Business 360 Applications, Governance, Access and Privacy, and Data Marketplace., allowing customers to track and understand their data. Geographically, the company generates maximum revenue from North America.

Share on Social Networks: